Category: Infectious Diseases

Infectious Diseases

Roche Receives CE Mark for Tuberculosis Blood Test

The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.

Infectious Diseases

Andes Virus Shifts Hantavirus Conversation for US Labs

Emerging Andes virus cases—capable of person-to-person transmission—are prompting US clinical labs to reassess hantavirus protocols and consider travel and epidemiologic exposures beyond rodent contact.

Infectious Diseases

Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe

Bruker has launched the MyGenius PRO molecular diagnostics system in Europe, offering fully automated, high-throughput PCR testing for infectious diseases with an initial focus on CMV, EBV, and BKV assays for clinical labs.

Emerging & Zoonotic Diseases

Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases

A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.

Flu & Respiratory Infections

Rapid Molecular Test for Flu and COVID-19 on FINDER Platform Gets FDA Clearance and CLIA-Waiver

The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.

Gastrointestinal Infections

FDA Clears Cepheid’s Multiplex GI Pathogen Panel

The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.

Sexually Transmitted Diseases

Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer

Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.